-
Triptolide (PG490): Phase-Aware Assay Design
2026-08-19
Triptolide (PG490) is a potent transcriptional inhibitor with applications in cancer research, immunology, and inflammatory disease models. This guide introduces a phase-aware strategy that connects its RNAPII-centered activity with cell-cycle transcription condensate biology to improve assay timing, controls, and interpretation.
-
Microfluidic Peptide–RNA Complexes for Lung Delivery
2026-08-18
This 2025 study shows that microfluidic mixing can reproducibly prepare LAH4-L1 and PEG12KL4 peptide complexes with siRNA or mRNA for nebulized pulmonary delivery. The complexes generated inhalable aerosols and retained RNA binding and in vitro transfection performance after vibrating-mesh nebulization, supporting further development of peptide-based mRNA delivery system research.
-
EPZ5676: A Practical DOT1L Inhibitor Workflow
2026-08-18
EPZ5676 combines sub-nanomolar biochemical potency with strong selectivity, making it a useful reference compound for H3K79 methylation inhibition and MLL-rearranged leukemia research. This guide connects biochemical testing, cellular target engagement, chromatin assays, and troubleshooting while clarifying how a rectal organoid study can inform—not replace—DOT1L-specific experiments.
-
Aconitase Activity Colorimetric Assay Kit Guide
2026-08-17
The Aconitase Activity Colorimetric Assay Kit provides a rapid biochemical readout of citrate-to-isocitrate conversion through color development at 450 nm. K2226 is useful for TCA cycle enzyme assay workflows and oxidative damage measurement, but its signal should not be interpreted as a direct measurement of reactive oxygen species or aconitase abundance.
-
α-Amanitin: From RNAP II Probe to Translational Insight
2026-08-17
α-Amanitin is more than a potent RNA polymerase II inhibitor: it is a causal perturbation tool for connecting transcriptional control to phenotype. This thought-leadership guide integrates mechanism, assay design, product strategy, and the emerging toxicology relevance of α-amanitin, including insights from CRISPR screening and STT3B biology.
-
CCK-8, Endogenous Opioids, and Withdrawal Anxiety
2026-08-16
Wen et al. showed that cholecystokinin octapeptide (CCK-8) reduces anxiety-like behavior in morphine-withdrawal rats through CCK1 receptor signaling and endogenous opioid involvement. The pharmacological design separates CCK1-dependent modulation from μ-opioid receptor-dependent effects, offering a mechanistic framework for opioid addiction and withdrawal studies.
-
Nonselective β-Blockers and HCT Engraftment
2026-08-15
The reference study shows that nonselective β-adrenergic receptor inhibitors can impair hematopoietic regeneration after allogeneic hematopoietic cell transplantation, whereas β1-selective inhibition had little comparable effect. By integrating mouse transplantation models with human clinical cohorts, the work identifies β-blocker selectivity, transplant type, posttransplant chemotherapy, and graft size as important determinants of engraftment risk.
-
Protease Inhibition as a Translational Strategy
2026-08-14
Proteases are not simply degradative enzymes; they are context-dependent regulators of signaling, cell death, proteostasis, and disease progression. This article examines how broad chemical perturbation can connect protease activity modulation with translational hypotheses, using the PSMD14–CARM1–FERMT1 axis in hepatocellular carcinoma as a mechanistic anchor. It also provides practical guidance for deploying the DiscoveryProbe™ Protease Inhibitor Library in biochemical, cellular, and high-content workflows while distinguishing exploratory evidence from disease-relevant validation.
-
Naloxone Hydrochloride as Translational Leverage
2026-08-14
A thought-leadership guide to using Naloxone hydrochloride as a mechanistic probe across opioid receptor signaling, neural stem cell biology, immune modulation, and behavioral research, with practical workflow guidance and translational strategy.
-
METTL16–SENP3–LTF Axis in HCC Ferroptosis
2026-08-13
Wang et al. identify a METTL16–SENP3–LTF regulatory axis that protects hepatocellular carcinoma cells from ferroptosis by controlling labile iron availability. The study combines molecular assays, organoids, xenografts, genetically engineered mice, and human samples to connect m6A-dependent RNA regulation with iron metabolism and tumor progression.
-
ER-Targeting Peptide Self-Assembly in Cancer Cells
2026-08-13
The reference study develops an alkaline-phosphatase-triggered peptide that self-assembles at the endoplasmic reticulum through a p-toluenesulfonamide targeting group. This design selectively increases ER stress and cancer-cell death while reducing the concentration dependence of earlier intracellular enzyme-instructed self-assembly strategies.
-
Glutathione Redox Logic in Hypoxic Tumors
2026-08-12
Hypoxia and immunometabolic competition can reshape tumor redox biology, but translational interpretation depends on measuring reduced and oxidized glutathione together. This thought-leadership guide connects mechanistic insight with a practical validation strategy using the GSH and GSSG Assay Kit.
-
Neomycin sulfate for RNA/DNA Assays
2026-08-12
Neomycin sulfate is more than an antimicrobial: its structure-selective effects support ribozyme, TAR, DNA-triplex, and ryanodine receptor assays. This workflow-led guide shows how to prepare aqueous stocks, separate genuine binding from ionic confounding, and use a rat allergic-rhinitis study as a careful model for multi-endpoint experimental design.
-
Biotin-16-UTP RNA Labeling Workflow
2026-08-11
Biotin-16-UTP provides a biotin-labeled uridine triphosphate for generating affinity-tagged RNA during in vitro transcription, supporting RNA detection and purification and downstream binding assays. It is intended for controlled research workflows only, not diagnostic or medical use, and requires cold storage and empirical optimization for each polymerase and RNA template.
-
AhR–RBX1/HSF1 Signaling in Acute Pancreatitis
2026-08-11
A 2025 study identifies an AhR–RBX1/HSF1 regulatory axis that links macrophage behavior, pancreatic acinar-cell stress, and tight-junction preservation during severe acute pancreatitis. Its combination of mouse modeling, primary-cell experiments, protein-interaction analysis, and pharmacological perturbation provides a mechanistic framework for studying epithelial barrier injury, while also highlighting unresolved questions about HSF1 regulation.